tiprankstipranks
Trending News
More News >
Medicamen Biotech Limited (IN:MEDICAMEQ)
:MEDICAMEQ
India Market

Medicamen Biotech Limited (MEDICAMEQ) Financial Statements

Compare
0 Followers

Medicamen Biotech Limited Financial Overview

Medicamen Biotech Limited's market cap is currently ₹5.29B. The company's EPS TTM is ₹1.966; its P/E ratio is 47.58; and it has a dividend yield of 0.26%. Medicamen Biotech Limited is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 1.63B₹ 1.79B₹ 1.41B₹ 1.15B₹ 1.13B
Gross Profit₹ 389.90M₹ 852.01M₹ 687.74M₹ 479.88M₹ 335.16M
Operating Income₹ 67.92M₹ 516.84M₹ 182.46M₹ 187.07M₹ 174.96M
EBITDA₹ 201.02M₹ 245.66M₹ 277.12M₹ 258.07M₹ 204.25M
Net Income₹ 71.08M₹ 109.31M₹ 148.44M₹ 148.98M₹ 121.29M
Balance Sheet
Cash & Short-Term Investments₹ 37.59M₹ 147.86M₹ 207.79M₹ 38.25M₹ 38.91M
Total Assets₹ 2.97B₹ 2.95B₹ 2.79B₹ 2.26B₹ 1.94B
Total Debt₹ 332.53M₹ 311.12M₹ 257.09M₹ 257.96M₹ 188.19M
Net Debt₹ 294.94M₹ 163.26M₹ 34.04M₹ 219.71M₹ 171.63M
Total Liabilities₹ 841.04M₹ 875.67M₹ 851.03M₹ 792.24M₹ 611.18M
Stockholders' Equity₹ 2.13B₹ 2.07B₹ 1.93B₹ 1.46B₹ 1.33B
Cash Flow
Free Cash Flow₹ -119.32M₹ -130.31M₹ -128.94M₹ -44.99M₹ -51.94M
Operating Cash Flow₹ -98.59M₹ -67.44M₹ -62.93M₹ 41.09M₹ 127.72M
Investing Cash Flow₹ -23.78M₹ -55.63M₹ -58.80M₹ -84.73M₹ -178.13M
Financing Cash Flow₹ 12.16M₹ 63.13M₹ 291.27M₹ 42.98M₹ 58.39M
Currency in INR

Medicamen Biotech Limited Earnings and Revenue History

Medicamen Biotech Limited Debt to Assets

Medicamen Biotech Limited Cash Flow

Medicamen Biotech Limited Forecast EPS vs Actual EPS